Results 201 to 203 of about 19,412 (203)

COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib

ESMO Open
Paloma Martin Martorell, José Luis González Larriba   +1 more
exaly  

Real-World Genomic Profile of EGFR Second-Site Mutations and Other Osimertinib Resistance Mechanisms and Clinical Landscape of NSCLC Post-Osimertinib

Journal of Thoracic Oncology
Jessica Lee, Pasi Janne, Russell Madison   +2 more
exaly  

Successful Osimertinib Rechallenge After Relapse Following Adjuvant Osimertinib: A Case Report

Journal of Thoracic Oncology
Nimit Singhal
exaly